Regencell Falls 20% — A $10 Billion Mystery with Zero Revenue

Regencell Bioscience (RGC) just went from a massive 60% rally to a sudden 20% plunge in less than 24 hours—and there is absolutely zero news to explain it. Despite having a market cap floating around $10 billion, the company has generated effectively no revenue and is trading at a staggering 5,000x book value. In this episode, we break down the dangerous mechanics behind this "roller coaster," the shadow of a DOJ probe, and why this stock is behaving less like an investment and more like a "lottery ticket in a burning building."